A Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Hepatitis C Virus Genotype 1

Gastroenterology & Hepatology December 2014, Volume 10, Issue 12 Nezam H. Afdhal, MD, Director of Hepatology, Beth Israel Deaconess Medical Center, Professor of Medicine, Harvard Medical School, Boston, Massachusetts G&H What […]

Surveillance for Hepatocellular Carcinoma

Gastroenterology & Hepatology November 2014, Volume 10, Issue 11 Sammy Saab, MD, MPH, AGAF, FAASLD, Professor of Medicine and Surgery, Assistant Professor of Nursing, Head, Outcomes Research in Hepatology, David […]

Complications of Acute Liver Failure

Gastroenterology & Hepatology October 2014, Volume 10, Issue 10 Santiago J. Munoz, MD, FACP, FACG, Director, Section of Hepatology and Liver Failure Unit, Hahnemann University Hospital, Professor of […]

Hepatocyte Transplantation

Gastroenterology & Hepatology September 2014, Volume 10, Issue 9 Ira J. Fox, MD, Director, Hepatocyte Transplant Program, Children’s Hospital of Pittsburgh, Professor of Surgery, University of Pittsburgh School of […]

The Microbiome and the Liver

Gastroenterology & Hepatology August 2014, Volume 10, Issue 8 Bernd Schnabl, MD Associate Professor, Department of Medicine, University of California, San Diego, La Jolla, California G&H What is meant […]

The Future of Hepatitis C Virus Therapeutics

July 2014, Volume 10, Issue 7 Paul Y. Kwo, MD, Professor of Medicine, Medical Director of Liver Transplantation, Division of Gastroenterology/Hepatology, Indiana University School of Medicine, Indianapolis, Indiana G&H How have […]

Advances in the Management of Hepatitis B Virus Infection

Gastroenterology & Hepatology June 2014, Volume 10, Issue 6 Hie-Won Hann, MD, Professor of Medicine, Jefferson Medical College, Director, Liver Disease Prevention Center, Division of Gastroenterology and Hepatology, Thomas Jefferson University […]

Management of Coagulopathy in Liver Disease

Gastroenterology & Hepatology May 2014, Volume 10, Issue 5 Stephen H. Caldwell, MD, Professor of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, University of Virginia School of Medicine, Charlottesville, […]

NASH in Special Populations

Gastroenterology & Hepatology April 2014, Volume 10, Issue 4 Ayako Suzuki, MD, PhD, MSc Associate Professor, Division of Gastroenterology and Hepatology, University of Arkansas Medical School, Director of Hepatology, Central Arkansas […]

Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis

Gastroenterology & Hepatology March 2014, Volume 10, Issue 3 Kris V. Kowdley, MD Director, Liver Center of Excellence, Digestive Disease Institute at Virginia Mason Medical Center, Clinical Professor […]

Early Detection of Hepatocellular Carcinoma Through Surveillance Using Biomarkers

Gastroenterology & Hepatology February 2014, Volume 10, Issue 2 Early Detection of Hepatocellular Carcinoma Through Surveillance Using Biomarkers Robert G. Gish, MD, Robert G. Gish Consultants, […]

Fibrosis and Cirrhosis in HCV Infection

Gastroenterology and Hepatology January 2014, Volume 10, Issue 1 Fibrosis and Cirrhosis in HCV Infection Mitchell L. Shiffman, MD, Director, Liver Institute of Virginia, Bon Secours Health System, Richmond […]

Acute Renal Dysfunction in Liver Cirrhosis

Acute Renal Dysfunction in Liver Cirrhosis Florence Wong, MBBS, MD, FRACP, FRCPC, Professor of Medicine, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada G&H How common is […]

Reversibility of Liver Fibrosis

Reversibility of Liver Fibrosis David A. Brenner, MD, Vice Chancellor for Health Sciences, Dean of the School of Medicine, University of California, San Diego, San Diego, California G&H What causes […]

Discontinuation of Nucleoside Analogs in Hepatitis B Virus Infection

Pietro Lampertico MD, PhD Assistant Professor 1st Division of Gastroenterology Fondazione IRCCS Ca’ Granda – Ospedale Maggiore Policlinico Università degli Studi di Milano Milan, Italy G&H […]

Delta Virus Infection: Epidemiology and Initiatives to Intercept It

Robert Gish, MD Medical Director, Clinical Hepatology The University of California, San Diego San Diego, California G&H How prevalent is hepatitis D virus, and does it […]

Use of Statins in Hepatocellular Carcinoma

Abby B. Siegel, MD, MS Assistant Professor of Medicine Columbia University College of Physicians and Surgeons New York, New York G&H What prompted study of statin […]

Diagnosis, Prognosis, and Management of Primary Sclerosing Cholangitis

Cyriel Ponsioen, MD, PhD Gastroenterologist and Clinical Research Investigator Department of Gastroenterology and Hepatology Academic Medical Center Amsterdam, The Netherlands G&H What underlies the symptoms of […]

Protease Inhibitor Therapy Post–Liver Transplantation in the Treatment of Hepatitis C Virus Infection

Satheesh P. Nair, MD Professor of Medicine Director of Transplant Hepatology University of Tennessee Health Science Center Memphis, Tennessee G&H What is the current consensus regarding […]

Management of Anemia in Patients Receiving Triple Therapy for Hepatitis C

A. Sidney Barritt IV, MD, MSCR Assistant Professor of Medicine University of North Carolina at Chapel Hill Chapel Hill, North Carolina G&H What effect does treatment-related […]